Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by HippygirL74on Feb 12, 2010 8:16pm
480 Views
Post# 16782533

RE: RE: RE: RE: RE: Why such a focus

RE: RE: RE: RE: RE: Why such a focusdaydream1, you've been watching too much tv.  You sound like Chicken Little when you talk about Greece.  i don't think you have a clear understanding of debt.  There are many kinds of debt, so if you think the national debt of  Greece is going to slow down sales of Pennsaid in Greece, you are ignorant.  LOL.  So Canada's debt is high and so is the USA's so does that mean that Mr. Smith will stop buying pain killers or food or health care products?  Besides, France and Germany will support Greece so don't count on the sky falling in Europe, killing Pennsaid sales.

In my thinking, 6 months is not a long time to wait for Pennsaid numbers to "trickle" down.  Business time is measured in quarters and years. 

And as for my "dreams", you clearly do not understand the significance of sunscreen or ointments or moisturizers in combination with topicals or possible UV effects on the skin with Pennsaid applied.  If the animal studies are successful, Pennsaid will have an advantage over Volteren Gel.  That's all i was saying and that translates into increased revenues.  Probably what Covidien was hoping for- just an educated guess and not some "dream". 

Hippy.

ps. thanks to Consultant99 for a good post.
Bullboard Posts